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Because of the growing need for publication space, Clini-
cal Orthopaedics and Related Research (CORR) was
established in 1953 by the Association of Bone and Joint
Surgeons [13] to provide an alternative source of publica-
tion to the Journal of Bone and Joint Surgery (then the only
American orthopaedic journal [8]). CORR always has
striven to provide readers with high-quality peer-reviewed
articles in the form of original research and survey mate-
rial. High quality depends on characteristics of the work
and on the reporting. While there is no lack of excellent
material on medical reporting and writing [7, 11, 12, 15,
17, 31], this article (and its predecessor on which this is
based [6]) is directed to CORR contributors. Toward that
end, I shall provide updated guidelines to our authors for an
approach to effective reporting.
Standardsofreporting, nolessthanstandardsofscientiﬁc
conduct (ethics) and standards of acceptable scientiﬁc
methods, change. Although ethics has always played a crit-
ical part in science and scientiﬁc reporting, recent societal
and regulatory expectations impose certain new require-
ments, while scientiﬁc advances require others. These
changeshavestimulatedconsiderablediscussion[1,2,9,14,
22–26] and CORR contributors are speciﬁcally directed to
the publications of the International Committee of Medical
Journal Editors [16] and The Committee on Publication
Ethics for general guidelines [1, 2]. CORR adheres to these
evolving guidelines, particularly regarding ethical issues.
Scientiﬁc advances in recent years include use of contem-
porary outcome measures, more sophisticated statistical
approaches, and increasing use and reporting of well-for-
mulatedresearchplans(particularlyinclinicalresearchsuch
as the CONSORT guidelines [18]). Although I shall not
detail these changing standards of reporting in my review, I
shall explicitly note several issues.
Scientiﬁc writing, no less than any other form of writing,
reﬂects a demanding creative process, not merely an act: the
process of writing changes thought. The quality of a report,
however, depends on the quality of thought in the study
design and the rigor of conduct of the research. Well-posed
questions or hypotheses intimately and inexorably interre-
late with study design and analysis. Well-posed hypotheses
or questions imply a studydesign and a study design implies
hypotheses or questions.
The effectiveness of a report relates to focus and brevity.
Attentiontoafewpointswillallowauthorstofocusoncritical
issues.Brevityisachievedinpartbyavoidingrepetition(with
a few exceptions to be noted), clear style [17], and proper
grammar [27, 31]. Few original scientiﬁc articles need be
longer than 3000 words. Longer articles (eg, 4000–5000
words) may be warranted if substantially novel methods are
reported, or if the article reﬂects a systematic survey of liter-
ature. Although writers should avoid redundancy, effectively
communicating critical information often means limited
repetition of the questions (or hypotheses or key issues) and
answers. The questions/hypotheses should appear in the
Abstract, Introduction, and Discussion, and the answers
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from these exceptions, authors should not repeat material.
Styles of writing are as numerous as authors, although
most journals publish guidelines for formatting a manu-
script, and many have more or less established writing
styles (eg, the American Medical Association Manual of
Style)[ 3]. CORR uses the AMA style as a general guide-
line. However, few scientiﬁc and medical authors have the
time to learn these styles. Therefore, within the limits of
proper grammar and clear, effective communication, and
our guidelines, we allow individual styles.
I shall outline the various elements of a traditional
archival report (Introduction, Materials and Methods,
Results, Discussion) and suggest a logical ﬂow for each.
Each of these sections should contain unique information,
andthesortofinformationrequiredforoneshouldnotappear
in the other; often authors mix rationale and methods,
methods and results, or results and discussion. Much of this
information relates to clinical studies, but the principles
apply to basic reports as well. Some reports, such as surveys
and systematic literature reviews or meta-analyses, require
individualizedstructures,althoughIshallalsodescribesome
generalizations applicable to these studies.
Introduction (500 words)
The Introduction, although typically the shortest of sections,
critically states the issues and formulates the rationale for
the questions or hypotheses. Its organization might differ
somewhat for a clinical report, a study of new scientiﬁc data,
or a description of a new method. Most studies, however, are
published to (1) report entirely novel ﬁndings (only occa-
sionally with substantive basic or clinical studies and rarely
a case report), (2) conﬁrm previously reported work (eg,
case reports, small preliminary series) when such conﬁr-
mation remains questionable, or (3) introduce or address
controversies in the literature when data and/or conclusions
conﬂict. Apart from certain surveys and other special
articles, one of these three purposes generally should be
apparent (and often explicit) in the Introduction. The ﬁrst
paragraph should introduce the general topic or problem
and suggest its importance, a second and perhaps a third
paragraph should provide the rationale for each question or
hypothesis, and a ﬁnal paragraph should state the questions,
hypotheses, or purposes.
Onemaythinkofformulatingrationaleandhypothesesas
Aristotelian logic (a modal syllogism) taking the form: If A,
B, and C, then D, E, or F. The premises A, B, and C reﬂect
accepted facts (rationale) whereas D, E, or F reﬂect logical
outcomes or predictions (questions or hypotheses). The
premises best come from published data, but when data are
not available, published observations (typically qualitative),
logical argument, or consensus of opinion can be used. The
strength of these premises is roughly in descending order
from data to observations or argument to opinion. D, E, or F
reﬂectlogicalconsequences.Foranysetofobservations,any
number of explanations (D, E, or F) logically follow.
Therefore, when formulating hypotheses (explanations),
researchers designing experiments and reporting results
should not be wed to a single explanation.
With the rare exception of truly novel material, when
establishing rationale authors should provide representative
(although not necessarily exhaustive) literature. Such ratio-
nale places a work within the body of literature. Writers
should merely state their premises and provide relevant
citationsandavoidmentionofauthors’namesordescription
of cited works; this places emphasis on ideas rather than on
investigators and studies. The exceptions to this approach
include a description of past methods when essential to
developing rationale for a new method or a mention of
authors’ names when important to establish historical prec-
edent. Ampliﬁcation of the citations may follow in the
Discussion when appropriate.
New treatment approaches require a speciﬁc sort of ratio-
nale: new interventions of any sort are intended to solve
certain problems with previous approaches and those prob-
lems should be explicitly noted. For example, new implants
(unless conceptually novel) typically will be designed
according to certain criteria to eliminate problems with pre-
vious implants. Therefore, if the intent is to report a new
treatmentand/oritsoutcome,thepremisesofthestudyshould
include those explicitly stated problems (with ranges of inci-
dence from the literature when possible) and they should be
properly referenced.
The ﬁnal paragraph logically ﬂows from the earlier ones
and should explicitly state the questions or hypotheses to
be addressed in terms of the study variables (independent,
dependent). Any issue not posed in terms of study variables
cannot be meaningfully addressed. Assignment of a Level
of Evidence in clinical studies requires a primary research
question, which in turn requires a key outcome variable.
Focus demands authors avoid answers to unposed ques-
tions and answers that are well described in the literature
(eg, reporting of heterotopic ossiﬁcation rates when the
question is whether an implant minimizes stress shielding).
Descriptive purposes (eg, ‘‘The purpose of our study was to
report the results…’’) are appropriate only for Level IV
studies (one cohort in therapeutic studies) and only when
the information is novel, an uncommon situation since
typically some information has been previously reported,
and the data will merely conﬁrm or refute previously
published data or will address or introduce a controversy. I
reiterate any well-posed question or hypothesis will be
reﬂected by the study design and statistical analysis; every
statistical analysis necessarily implies speciﬁc questions.
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In principle, the Materials and Methods should contain
adequate detail for another investigator to replicate the
study. This principle applies to surveys or systematic
reviews as well as to archival manuscripts since search
strategies should be repeatable. In practice, such detail is
often neither practical nor desirable because many methods
will have been published previously (and in greater detail)
and because long descriptions violate the principle of
brevity. Nonetheless, the Materials and Methods section
typically will be the longest section.
The Materials and Methods should ﬂow in the approxi-
mate chronological order in which the study was conducted.
For a clinical study, these elements entail (1) a study design
(including key variables), (2) a power analysis (for all
studies statistically comparing two or more groups), (2) key
patient demographics (ie, those which could be confound-
ing variables), (3) a description of surgery if any, (4)
postoperative care, (5) a description of valid and reliable
methods to measure study independent variables (eg, fol-
lowup clinical, radiographic, or histologic outcomes in a
clinical study and independent variables in all statistical
analyses), and (6) their statistical analysis. Basic studies
obviously do not contain patient demographics or surgery or
postoperative care but generally require the other elements.
At the outset, the reader should grasp the basic study
design. The study design should complement the questions
or hypotheses just raised and must similarly state the key
study variables. Level IV therapeutic studies contain a
single cohort, but Level I to III studies necessarily describe
two or more cohorts (independent variables); these must be
outlined in the study design, as well as the key dependent
variables. Level I to III studies also require a power anal-
ysis of the key outcome variable of the primary research
question. This analysis should be based upon a clinically
meaningful (and not merely statistically signiﬁcant) effect
size. That is, what difference in that variable or measure
would result in a substantially different clinical outcome?
A judgment as to meaningful differences should be based
upon the literature when available or an educated guess
when not; readers may judge whether they agree or dis-
agree with the choice.
The ﬁrst paragraph or two should also contain, in addition
to the study design (and power analysis when appropriate), all
relevant clinical data (Appendix 1). For a given study, not all
information may be essential, but authors can use the types of
data in the appendix as a checklist. Minimum followup
should be sufﬁcient to meaningfully address the questions
being posed. This will necessarily differ depending upon the
question. Questions relating to postoperative mortality rates
may require, for example, only 30 to 90 days of followup,
while those for questions relating to implant loosening may
require 5 years. Authors must state the minimum followup
time followed by the mean (or median when more appro-
priate) and range.
Clinical reports must state inclusion and exclusion cri-
teria and whether the series is consecutive or selected; if
selected, criteria for selection should be stated. The reader
should understand from this description all potential sour-
ces of bias such as referral, diagnosis, exclusion, recall, or
treatment bias. This includes the manner in which inves-
tigators selected the patients. Consecutive inclusion implies
all patients with a given diagnosis (not typically a given
treatment) are included, while selective implies patients
with a given diagnosis but selected according to certain
explicit criteria (eg, state of disease, choice of treatment).
Often in a surgical series, patients to be reported are
selected for a given treatment (eg, type of surgery or
implant) rather than a given diagnosis. This occurs when
some patients with the diagnosis have the treatment in
question, but other patients treated during the same time
frame with the same diagnosis have a different treatment or
treatments; in this case, authors must specify the criteria
used to select and exclude the treatment in question.
Referral bias will typically be known to readers based upon
the institution or institutions from which the study arises,
although occasionally referral bias requires ampliﬁcation in
Materials and Methods.
All patient studies must include a description of poten-
tially confounding demographic information at the time of
entry into the study and at the time of surgery; this infor-
mation should appear in the ﬁrst paragraph or two. With a
single cohort, this information will reﬂect referral or
selection bias. With more than one cohort (ie, Level I–III
studies), authors should provide a statistical analysis of
these potentially confounding baseline variables between
the groups; thus the reader immediately knows whether the
groups are biased in any important way. Potentially biasing
differences should be described not only statistically but
also in clinically meaningful terms.
Missing data confound many statistical analyses. Authors,
particularly those of retrospective reviews, should note what
dataare missingandinthe statisticaldescriptionsshouldnote
how they dealt with missing data.
Any treatment (including surgery) should be brieﬂy
described, particularly when surgeons apply unique approa-
chesorwhen all patientsdid not undergo essentiallyidentical
procedures. Previously described approaches require only
brief mention with citations to those methods.
All relevant aspects of posttreatment followup care
should be described, whether nonsurgical or surgical. If
that treatment might reasonably be expected to inﬂuence
outcome, it should be described in some detail. Authors
must note whether the treatment was uniform among all
patients or varied. If varied, they should specify the
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study involves multiple cohorts, whether the treatment
applications statistically differed between the cohorts.
If authors use statistical analysis, a paragraph should
appear at the end of Materials and Methods stating all sta-
tistical tests used. Statistical tests imply speciﬁc questions
or hypotheses, so the methods and their descriptions should
be coherent with and in the same order as the questions or
hypotheses posed in the Introduction. Authors must specify
the variables analyzed with each test. All statistical tests are
associated with assumptions, and when it is not obvious the
data would meet those assumptions, the authors either
should provide the supporting data (eg, data are normally
distributed, variances in groups are similar) or use alterna-
tive tests. Although it is common to choose a level of alpha
of 0.05 and a beta of 0.80, these levels are somewhat
arbitrary and not always appropriate. In the case where the
implications of an error are very serious (eg, missing the
diagnosis of a cancer), different alpha and beta levels might
be appropriate in the study design to assess clinical or
biological signiﬁcance. Sterne and Davey Smith [29] pro-
vide historical and theoretical reasons why attempting to
suggest something is important or not based on an arbitrary
threshold level was not the intent of the developers and is
inappropriate. We suggest readers avoid such thresholds
and rather state the exact probability value in Results to
demonstrate the strength of the evidence.
Results (500 words)
If the questions or issues have been adequately focused in
the Introduction, the Results section need not be long.
Authors may need an initial paragraph or two to persuade
the reader of the validity of the methods and should have
one paragraph addressing each explicitly raised question or
hypothesis; ﬁnally, an additional paragraph or two might be
useful to report new and unexpected ﬁndings. That is,
authors should provide a one-to-one correspondence of
questions and answers. Patient information in Results
should be limited to that at the time of followup to answer
the questions raised in the ﬁnal paragraph of the Intro-
duction while patient information at the time of entry into
the study or at the time of surgery or before assessing the
independent variables should appear in Materials and
Methods (these descriptions, while often in the form of
data, should be considered materials).
The ﬁrst (topic) sentence of each paragraph should state
the point or answer the question. Well-posed questions can
be unambiguously answered ‘‘yes’’ or ‘‘no,’’ and well-
formulated hypotheses can be unambiguously conﬁrmed or
refuted. When the reader considers only the ﬁrst sentence in
each paragraph in Results, the logic of the authors’
interpretations should be clear. Parenthetic reference to all
ﬁgures and tables forces the writer to textually state the
interpretation of the data; the important material is the
authors’ interpretation of the data, not the data.
Statistical reporting of data deserves special consider-
ation. Stating some outcome is increased or decreased (or
greater or lesser) and parenthetically stating the p (or other
statistical) value immediately after the comparative terms
more effectively conveys information than merely stating
two values and then providing a probability value (in the
same or a following sentence) without stating how or in
which direction the two values differ. Avoiding the terms
‘‘statistically different’’ or ‘‘signiﬁcantly different’’ but
providing the exact probability value lets the reader
determine whether they will consider the statistical value
biologically or clinically important, regardless of statistical
signiﬁcance. Although a matter of philosophy and style,
actual p values convey more information than stating a
value less than some preset level. Furthermore, as Motul-
sky notes, ‘‘When you read that a result is not signiﬁcant,
don’t stop thinking . . . First, look at the conﬁdence interval
. . . Second, ask about the power of the study to ﬁnd a
signiﬁcant difference if it were there’’ [20]. This approach
will give the reader a much greater sense of biological or
clinical importance. Authors should avoid making infer-
ences from nonsigniﬁcant trends unless they believe their
study underpowered to answer that question; in that case,
they should provide a power analysis.
Discussion (1000 words)
The Discussion in a CORR article should contain speciﬁc
elements: a restatement of the problem or question, an
exploration of limitations and assumptions, a comparison
and/or contrast with information (data, opinion) in the lit-
erature, and a synthesis of the comparison and the author’s
new data to arrive at conclusions. The restatement of the
problem or questions need be only brief for emphasis.
I prefer an exploration of assumptions and limitations
immediately follow the brief introductory paragraph in
Discussion rather than appear at the end because inter-
preting what will follow depends on these limitations.
Failure to explore limitations suggests the author(s) either
do not know or choose to ignore them, potentially mis-
leading the reader. Exploration of these limitations need be
only brief, but all critical issues must be raised, and the
reader should be persuaded by logical argument they do not
jeopardize the conclusions. Given the expense and effort
for substantial prospective studies, it is not surprising most
published clinical studies are retrospective. Such studies
often are criticized unfairly for being retrospective, but that
does not necessarily negate either validity or value of a
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provided and will continue to provide most of the infor-
mation on which clinicians make decisions. However,
authors reporting retrospective studies should describe any
speciﬁc limitations relating to their study; these might
include loss to followup, difﬁculty matching cohorts (if
more than one), missing data, and the various forms of bias
more common with retrospective studies.
Next, the authors should compare and/or contrast their
datawithdatareportedintheliterature.Someofthesereports
may include those cited as rationale in the Introduction.
Quantitative comparisons most effectively persuade the
reader the data in the study are in the ballpark, and tables or
ﬁgures efﬁciently convey that information. However,
because of the peculiarities of each study, the data or
observations might not be strictly comparable, but even in
such cases it would be unusual if the literature would not
contain at least trends or opinions for comparison. Discrep-
ancies should be stated and explained when possible; when
an explanation of a discrepancy is not clear, that also should
be stated. Conclusions based solely on data in the paper
seldom are warranted because the literature almost always
containspreviousinformation.Thequalityofanyreportwill
depend on the substantive nature of these comparisons.
Finally, the author(s) should synthesize their data with
that in the literature. No critical data should be overlooked
because contrary data might effectively refute an argument.
(From a logical point of view, many consistent observa-
tions do not conﬁrm an explanation because a single
inconsistent observation can disprove an explanation.) That
is, the ﬁnal conclusions must be consistent not only with
the new data presented but also with that in the literature.
Surveys, Systematic Reviews, Meta-analyses
The format for these three types of reports necessarily
differs from those reporting original data. However, many
of the principles noted above apply. These articles still
require an Abstract, an Introduction, and a Discussion. The
Introduction still requires focused issues and a rationale for
those issues. Authors should convey to readers the unique
aspects of their surveys that distinguish them from other
available material (eg, monographs, book chapters). The
issues should be posed in the ﬁnal paragraph of the Intro-
duction. As with an archival article reporting original
material, the Introduction to a survey typically need not be
longer than four paragraphs. Longer Introductions tend to
lose focus, so the reader is not sure what novel information
will be presented.
The sections after the Introduction and before the Dis-
cussion will be unique to the particularsurveybutneed tobe
organized in a coherent fashion. Headings (and subheadings
when appropriate) should follow parallel (grammatical)
construction and reﬂect explicitly raised questions (Intro-
duction) and generally reﬂect analogous topics (eg,
diagnostic categories, choices of methods, choices of sur-
gical interventions). If the reader considered only the
headings, the logic of the survey (as reﬂected in the Intro-
duction) should be clear.
Systematicreviewsandmeta-analysesarespecialsortsof
studiesmeetingspeciﬁccriteriaofconduct[5,19,30,32].In
these articles the questions must be carefully deﬁned and
literature searches are conducted with inclusion criteria and
stated search criteria including ﬁeld tags appropriate to the
questions. A Materials and Methods section will specify all
databases searched, including hand searches of articles later
identiﬁed as appropriate for initial consideration. The
number of articles found by each search must be speciﬁed as
shouldbethenumberexcludedbyexplicitexclusioncriteria.
Authors must then state how they selected the ﬁnal group of
articles reviewed. These procedures allow an independent
individual to more or less replicate the review (realizing
manyifnotmostsourcestodayareelectronicandthenumber
of articles for a given search criterion is in continual ﬂux).
Forclinicalarticles,authorsmuststatewhetherandhowthey
judgedstudyquality;tablesareoftenhelpfulinsummarizing
study quality. Meta-analyses require, in addition to those
elements for a systematic review, additional requirements
for analysis [5, 19]. These include a requirement for judging
and accounting for study quality. Systematic reviews and
meta-analyses should contain a traditional Results section
that focuses on answers to the questions addressed in the
Introduction (and not the material used to arrive at
the answers). That is, a systematic review should synthesize
the material and not merely provide summaries of individual
articles. Tables or appendices may be used to provide sum-
mariesofmaterialwhennecessarytosupportandsupplement
the synthesis. If select individual articles require summaries,
they should appear in Materials and Methods, not in Results.
The Discussion sections of surveys, systematic reviews,
and meta-analyses synthesize the reviewed literature into a
coherent whole and within the context of the novel issues
stated in the Introduction. The limitations should reﬂect
those of the literature in general, however, in addition to
those of a given study. Those limitations will relate to gaps
in the literature, which preclude more or less deﬁnitive
assessment of diagnosis or selection of treatment, for
example. Controversies in the literature should be brieﬂy
explored. Only by exploring limitations will the reader
appropriately place the literature in perspective. Authors
should end the Discussion by summary statements similar
to those that will appear at the end of the Abstract in
abbreviated form.
In general, a survey requires a more extensive literature
review than an archival article, although this depends on
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(eg, osteoporosis) could not be comprehensively refer-
enced, even in an entire monograph. However, authors
need to ensure a survey is representative of the entire body
of literature, and when that body is large, many references
are required.
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Abstract (200 words)
Generally, the Abstract should be written after the entire
manuscript is completed. The reason relates to how the
process of writing changes thought and perhaps even
intent. Only after careful consideration of the data and a
synthesis with the literature can author(s) write an effective
abstract.
Many readers, professional and lay alike, now access
medical and scientiﬁc information via Web-based
databases rather than browsing hard copy material.
Regardless of access, since the reader’s introduction occurs
through titles and abstracts, substantive titles and abstracts
more effectively capture a reader’s attention. Because of
lay access to abstracts, these should be written in accessible
language and draw conclusions that would not be misin-
terpreted by a lay reader. Whether a reader will examine an
entire article often will depend on an abstract with com-
pelling information. A compelling abstract contains the
questions or purposes, the methods, the results (most often
quantitative data), and the answers to the questions (con-
clusions). Each of these may be conveyed in one or two
statements. Comments such as ‘‘this report describes…’’
convey little useful information.
Clinical studies (ie, those involving data from patients)
require a Level of Evidence when they relate to treatment,
diagnosis, prognosis, or economic decisions. Authors must
provide below the Abstract a Level of Evidence and study
description for the primary research question (our Web site
contains the guidelines).
Title Page
While the Abstract is important in capturing a reader’s
attention, the title is likely even more important owing to
Internet methods of searching and browsing. Declarative
titlesraisingoransweringquestionsinafewbriefwordswill
farmorelikelydothisthantitlesmerelypointingtothetopic.
A title such as ‘‘Bisphosphonates Reduce Bone Loss’’
effectively conveys the main message and readers will more
likely remember that message and read (and cite) the paper
than they might if the title were ‘‘The Effect of Bisphos-
phonates on Bone Loss.’’ As noted earlier, studies with
multiple cohorts or groups statistically analyzed for differ-
ences require a power analysis of effect size based on
meaningfulbiologicalorclinicaldifferences;authorsshould
consideratitlebaseduponthosekeyquestionsorhypotheses
used for the power analysis. CORR generally limits titles to
80 characters including spaces.
CORR requires authors to acknowledge potential con-
ﬂicts of interest. Our required cover letter contains four
choices, one of which authors must select. This statement
then becomes the basis for a standard statement that in our
decision letters we request authors place on their Title Page.
When reporting studies involving human or animal
subjects, authors must obtain prior approval of the insti-
tutional review board or ethics committees according to the
laws and regulations of their countries. Informed consent
for participation in a clinical study (a different form of
consent from that required for treatment) must be stated
where appropriate. In the United States, Institutional
Review Board approval is required for studies using any
information with patient identiﬁers, even if patients are not
seen, although expedited review may be appropriate [21].
Similarly, animal studies require approval of institutional
animal welfare committees. Such approval must be stated
on the Title Page and may be stated in the ﬁrst paragraph of
Materials and Methods.
Finally, the Title Page must contain full contact infor-
mation of the corresponding author.
References
References should derive primarily from peer-reviewed
journals, standard textbooks or monographs, or well-
accepted and stable electronic sources (eg, NIH or FDA
Web sites). For citations dependent on interpretation of
data, authors generally should use only high-quality peer-
reviewed sources. Abstracts and submitted articles should
not be used because many in both categories frequently do
not pass peer review [4, 10, 28]. Accepted articles in press
in peer-reviewed journals may be used if the anticipated
date of publication is within a time frame for the ﬁnal
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articles contain methods or data crucial to interpret mate-
rial in a submitted manuscript, authors should include a
copy in the submission for review by referees and editors.
CORR uses a modiﬁed AMA reference style. The
modiﬁcations include listing of all authors, rather than only
the ﬁrst six authors, italicization of journal titles, and
elimination of issue number.
Figures and Tables
Figures and tables should generally complement, not
duplicate, material in the text. They compactly present
information that would be difﬁcult to describe in text form.
(Material, which may be succinctly described in text, should
rarely be placed in tables or ﬁgures.) Clinical studies, for
example, often contain complementary tables of demo-
graphic data, which, although important for interpreting the
results, are not critical for the questions raised in the paper.
Well-focused papers contain only one or two tables or ﬁg-
ures for every question or hypothesis explicitly posed in the
Introduction. Additional material may be used for unex-
pected results.
Well-constructed tables are self-explanatory and require
only a brief title. Every column must contain a header
(with units when appropriate). Brief footnotes may be
necessary to explain abbreviations or levels of statistical
signiﬁcance.
Figures typically need some explanation, including the
meaning of symbols. Some ﬁgures will illustrate methods
and may not require more than a brief explanation. Data
ﬁgures should be provided only to address explicitly raised
questions or hypotheses (Introduction) or unanticipated
ﬁndings; data not directly addressing such questions should
be avoided. In addition to whatever data descriptions are
required, a ﬁgure legend should contain the major point
within the framework of the questions raised. A reader
should be able to read the questions in the last paragraph of
the Introduction and then ﬁnd the answers in the ﬁrst sen-
tence of each paragraph in Results and in the ﬁgure legends.
Illustrations for a single patient should all have the same
number and be labeled ‘‘A,’’ ‘‘B,’’ ‘‘C,’’ etc. Each ﬁgure
requires a separate legend and presumably makes a separate
point. Legends should be written in complete sentences.
Summary
Effective writing demands three elements: focus, logical
ﬂow, and brevity. Focus is achieved by posing clear
questions or hypotheses in terms of study variables and
then describing the measures required only for those
variables and reporting data only related to the questions or
hypotheses. In the course of investigations, authors fre-
quently collect far more data than is required for speciﬁc
questions and they ﬁnd it painful to discard data acquired
with often great effort and expenditure of resources. Yet,
attempting to report more data than required to address the
questions or hypotheses merely loses readers. Logical ﬂow
is attained by following a clear structure. The four elements
of an archival paper provide overall structure, but each
element must also be logically structured: the Introduction
with rationale and questions posed in order of importance,
the Materials and Methods with a more or less chrono-
logical order of obtaining the materials and then describing
the methods of assessing each variable, the Results by
answering the questions in order of importance and
appearance, and ﬁnally a Discussion that synthesizes the
key data for each question with that in the literature.
Authors should ensure each section contains only material
appropriate for that section; for example, methods should
not be described in Results. Brevity is achieved by
avoiding repetition of material, eliminating data and dis-
cussion not required for the questions, and ensuring each
section contains only the crucial information. Through
these principles, authors can achieve a wider and more
interested audience.
Practical Tips
1. Focus the data on addressing explicit hypotheses or
questions; avoid the urge to report data not directly
related to the hypotheses or questions, regardless of
how painstaking it was to collect.
2. Read only the ﬁrst sentence in each paragraph through-
out the text to ascertain whether those statements
contain all critical material and the logical ﬂow is clear.
3. Avoid in the Abstract comments such as ‘‘this report
describes…’’ Such statements convey no substantive
information for the reader.
4. Avoid references and statistical values in the Abstract.
5. Avoid using the names of cited authors except to
establish historical precedent. Instead, state the point
documented in the article or articles and provide
citation. For the most part, it is the data or the
conclusions of the authors the reader ﬁnds crucial in
scientiﬁc arguments, not the names of authors.
6. Avoid in the ﬁnal paragraph of the Introduction
descriptive purposes such as ‘‘we report our data…’’
Such statements fail to focus the reader’s (and
writer’s!) attention on the critical issues (and do not
include mention of study variables).
7. Parenthetically refer to tables and ﬁgures and avoid
statements in which a table or ﬁgure is either subject or
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123object of a sentence. Parenthetic reference places
emphasis on interpretation of the information in the
table or ﬁgure and not the table or ﬁgure.
8. Regularly count words from the Introduction through
Discussion.
9. Read the guidelines for publishing in CORR (or any
other journal) before submission. Those guidelines
generally will need to be met in any case.
Appendix 1
Content and Organization for Materials and Methods
for Studies on Living Patients
These instructions apply when there is a need for Materials
and Methods and Results sections. They do not apply to
case reports, Orthopaedic-Radiology-Pathology con-
ferences, or selected other unusual articles (eg, survey
articles, articles where patient material is used to address
nonclinical questions).
Description of Materials and Methods generally should
be in past tense. Change passive to active voice when
possible but not necessarily every sentence.
No subheadings (in most cases, a subheading merely
duplicates the keypoint ofa well-formulated leadsentence).
Paragraph 1
At the beginning of Materials and Methods, authors must
clearly describe the study design in the ﬁrst paragraph.
(Please see our published table of Levels of Evidence for
examples of descriptions of clinical study designs.) The
study design should complement the questions just raised
in the Introduction, and the questions should be inferred
from the study design. Ensure the study design describes
a method to answer the primary research question. If an
IRB statement is appropriate, it can go at the end of the
ﬁrst paragraph, but this is not required since we require it
on the title page.
Level I to III must include a description of independent
(two or more groups) and dependent (outcome) variables.
Level IV must include a description of dependent
(outcome) variables (there is only one group).
Level I to III (one to two paragraphs)
• Study design (sometimes one paragraph) including
description of experimental and control subjects
• Power analysis including clinically important effect size
• Total potentially eligible patient base (ie, with the
diagnosis or the treatment) including time over which
patients enrolled
• Must state whether patients consecutive or selected
• Patient selection methods with inclusion and exclusion
criteria
• If a study of a treatment (eg, surgery), list all indications
for treatment, any prerequisites, and contraindications
• Randomization scheme if groups randomly assigned
• Numbers of patients excluded and for what reasons (eg,
QUORUM algorithm)
• Final numbers of patients studied in each group
• Relevant demographic factors (age, gender, time to
operation, etc)
• Comparability of relevant demographic factors if multi-
ple groups
• Minimum and range of followup time
• Number of patients lost to followup
• Ethical (IRB) board approval
Level IV (one paragraph)
• Total potentially eligible patient base (ie, with the
diagnosis or the treatment) including time over which
patients enrolled
• Must state whether patients consecutive or selected
• Patient selection methods with inclusion and exclusion
criteria
• If a study of a treatment (eg, surgery), list all indications
for treatment, any prerequisites, and contraindications
• Numbers of patients excluded and for what reasons
• Final numbers of patients
• Relevant demographic factors (age, gender, time to
operation, etc)
• If historical controls from the literature for comparison,
so state
• Minimum and range of followup time
• Number of patients lost to followup
• Ethical (IRB) board approval
Paragraph 2
Describe surgical procedures.
Paragraph 3
Describe outcome measures. Unless measures are widely
used (eg, range of motion), you should cite sources that
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123validate the measures. If subjective measures dependent
upon human observation (eg, clinical examinations,
radiographs, histologic slides are used), you must state
numbers of observers and parenthetically note initials of
observers, whether authors or others (others should be
noted in Acknowledgments).
Paragraph 4
In the ﬁnal paragraph (or two), explain (and justify if
appropriate) all statistical tests. Specify which tests were
used to analyze which sets of data. State (and justify if
appropriate) level of signiﬁcance. Note software used
(manufacturer, city, state or country).
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